Antibody Drug Conjugates Market By Drug Type (Monomethyl Auristatin E (MMAE), Monomethyl Auristatin F (MMAF), Maytansinoids (DM1, DM4), Calicheamicin, Duocarmycin, Pyrrolobenzodiazepine (PBD), Doxorubicin Derivatives, Others), By Target Antigen (HER2, CD30, CD33, CD22, TROP-2, Nectin-4, BCMA, CD79b, EGFR, Others), By Technology (Chemical Conjugation, Site-Specific Conjugation, Polymer-Based Conjugation, Click Chemistry, Liposomal Delivery), By Application (Breast Cancer, Lymphoma, Leukemia, Lung Cancer, Urothelial Cancer, Ovarian Cancer, Gastric Cancer, Others), By End-User (Hospitals, Specialty Cancer Centers, Research Institutes, Ambulatory Surgical Centers (ASCs)), Global Market Size, Segmental Analysis, Regional Overview, Company Share Analysis, Leading Company Profiles, and Market Forecast, 2025–2035.

Published Date: May 2025 | Report ID: MI2680 | 220 Pages


Report Coverage:

By Drug Type

  • Monomethyl Auristatin E (MMAE)
  • Monomethyl Auristatin F (MMAF)
  • Maytansinoids (DM1, DM4)
  • Calicheamicin
  • Duocarmycin
  • Pyrrolobenzodiazepine (PBD)
  • Doxorubicin Derivatives
  • Others

By Target Antigen

  • HER2
  • CD30
  • CD33
  • CD22
  • TROP-2
  • Nectin-4BCMACD79b
  • EGFR
  • Others

By Technology

  • Chemical Conjugation
  • Site-Specific Conjugation
  • Polymer-Based Conjugation
  • Click Chemistry
  • Liposomal Delivery

By Application

  • Breast Cancer
  • Lymphoma
  • Leukemia
  • Lung Cancer
  • Urothelial Cancer
  • Ovarian Cancer
  • Gastric Cancer
  • Others

By End User

  • Hospitals
  • Specialty Cancer Centers
  • Research Institutes
  • Ambulatory Surgical Centers (ASCs)

By Region

North America

  • U.S.
  • Canada

Europe

  • U.K.
  • France
  • Germany
  • Italy
  • Spain
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Singapore
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America

Middle East & Africa

  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

List of Companies:

  • Pfizer Inc.
  • Johnson & Johnson
  • AbbVie Inc.
  • Merck & Co., Inc.
  • Roche Holding AG
  • AstraZeneca PLC
  • Bristol Myers Squibb
  • Novartis AG
  • Sanofi S.A.
  • GlaxoSmithKline plc (GSK)
  • Eli Lilly and Company
  • Novo Nordisk A/S
  • Amgen Inc.
  • Gilead Sciences, Inc.
  • Bayer AG

Maximize your value and knowledge with our 5 Reports-in-1 Bundle - over 40% off!

Our analysts are ready to help you immediately.